JAN 2018
16 new patents,
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
|
WO-2018009735
|
PALBOCICLIB
|
TEVA
|
CANCER
| |
2
|
WO-2018009609
|
OLINCIGUAT
|
IRONWOOD
|
Cancer; Duchenne dystrophy; Dyspepsia; Motor neurone disease; Osteoporosis; Sickle cell anemia; Spinal muscular atrophy
| |
3
|
WO-2018009444
|
VENETOCLAX
|
CONCERT
|
Bcl-2 protein inhibitor
| |
4
|
WO-2018008569
|
NASTORAZEPIDE
|
ZERIA
| Gastritis; Gastroesophageal reflux; Zollinger-Ellison syndrome | |
5
|
WO-2018008042
|
SELEXIPAG
|
MAITHRI
| Pulmonary artery hypertension | |
6
|
WO-2018007986
|
CARIPRAZINE
|
GEDEON
|
Bipolar I disorder; Schizophrenia
| |
7
|
WO-2018007984
|
DACLATASVIR
|
LUPIN
|
Hepatitis C virus infection
| |
8
| WO-2018007930 |
ICATIBANT
|
EMCURE
| Hereditary angioedema | |
9
|
|
PALBOCICLIB
|
DR REDDYS
|
Metastatic breast cancer
| |
10
|
WO-2018007919
|
SACUBITRIL VALSARTAN
|
NOVARTIS
|
Cardiac failure; Hypertension
| |
11
|
WO-2018007842
|
PIMAVANSERIN
|
EGIS
| Neurodegenerative disease | |
12
|
|
THAPSIGARGIN
|
LEO
|
CANCER
| |
13
|
WO-2018006870
|
GALUNISERTIB
|
CRYSTAL
| Carcinosarcoma; Hepatocellular carcinoma; Myelodysplastic syndrome | |
14
|
WO-2018006811
|
VELTAPASVIR
|
SHENZEN
|
Hepatitis C virus infection
| |
15
|
US-20180002273
|
DESVENLAFXINE
|
ALPARIS
|
Depression; Hot flashes; Major depressive disorder
| |
16
|
EP-03263552
|
OBETICHOLIC ACID
|
ZENTIVA
| Primary biliary cirrhosis | |